Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.2 is now shown on the page. Several sponsor- and document-related footer items were removed, which changes how study documents and sponsor context are accessed while leaving the core trial details unchanged.SummaryDifference16%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page adds a recruitment status note and new guidance sections to help users join or understand the study, and updates the revision tag to v3.6.0 while adjusting the Intervention/Treatment heading.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now displays the latest revision label Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page versioning rather than a substantive content change.SummaryDifference0.0%

- Check49 days agoChange DetectedA new revision label v3.5.4 has been added, replacing the previous v3.5.3. This indicates an update to the page's revision history rather than any changes to the study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThis change adjusts how the Chilean Valparaíso location is presented (e.g., region wording) while keeping the same city/address line for that site. It also reflects an automated site version/revision update without altering the study’s scientific or participant-relevant details.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.